Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/01/23 → 31/12/23 |
Funding
- Diabetes Research Foundation of WA: A$60,000.00
Dual Inhibition of SGLT1 and 2 with Sotagliflozin– a Novel Approach to Maximize Cardiorenal Protection in Type 1 Diabetes.
- Herat, Lakshini (Chief Investigator)
- Matthews, Vance (Investigator 02)
- Schlaich, Markus (Investigator 03)
- Sebastian, Oltean (Investigator 04)
- Rakoczy, Elizabeth (Investigator 05)
- Matthews, Jen (Investigator 06)